AKTSAktis Oncology, Inc. Common stock

CSNasdaq (XNAS)·USD

Identity

Security key: 11548
Ticker: AKTS
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2026-01-09
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: AKTS

Detail

Enriched 2026-08-14 20:47

Market cap: $1,326,658,728
Shares outstanding (class): 53,404,618
Shares outstanding (weighted): 55,277,447
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 79
Location: BOSTON, MA
Homepage: https://www.aktisoncology.com
Description: Aktis Oncology Inc is a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations, including those not addressed by existing platform technologies. The company specializes in developing targeted alpha radiopharmaceuticals for solid tumors such as breast, lung, colorectal, bladder, and liver cancers. Its pipeline products include AKY-1189 and AKY-2519, focusing on solid tumors. The company has one operating and reportable segment focused on the research and development of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company generates revenue from Collaboration agreement.

Market cap and share counts drift.

Funds holding this security

59 funds · 61 positions · $72.64M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
T. Rowe Price Small-Cap Stock Fund, Inc. T. ROWE PRICE SMALL-CAP STOCK FUND, INC.	—	$10.96M	0.14%	612,547 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$10.84M	0.00%	605,835 NS	FIGI
Eventide Healthcare & Life Sciences Fund MUTUAL FUND SERIES TRUST	—	$9.07M	0.57%	507,000 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$8.27M	0.01%	462,308 NS	FIGI
T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC.	—	$5.97M	0.05%	333,745 NS	FIGI
T. Rowe Price Institutional Small-Cap Stock Fund T. Rowe Price Equity Funds, Inc.	—	$5.74M	0.13%	320,750 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$3.75M	0.00%	209,675 NS	FIGI
T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC.	—	$3.66M	0.04%	204,347 NS	FIGI
T. Rowe Price New Horizons Fund, Inc. T. ROWE PRICE NEW HORIZONS FUND, INC.	—	$3.52M	0.03%	196,823 NS	FIGI
Meridian Small Cap Growth Fund Meridian Fund Inc	—	$1.89M	0.80%	105,570 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$1.53M	0.01%	85,457 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$1.44M	0.01%	80,222 NS	FIGI
BlackRock Health Sciences Term Trust —	—	$1.05M	0.10%	58,563 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$587.4K	0.01%	32,834 NS	FIGI
BlackRock Health Sciences Trust —	—	$415.6K	0.08%	23,229 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERAKTS
FIGI_COMPOSITEBBG00ZQS8KZ1
FIGI_SHARE_CLASSBBG00ZQS8L07
CIK0002035832
ISINUS01021M1045
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: The security is common stock of a pharmaceutical preparations company per SIC 2834.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.